Pharmaceutical Industry

Page 2 of 100

Mark Cuban sits on a white chair in front of a purple background, speaking into a microphone.
North America

Mark Cuban says Trump’s new drug platform could succeed if it forces pharma managers to change: ‘If that happens, Trump gets all the credit’

By
October 2, 2025
Mark Cuban
Success

Mark Cuban says his best investment of all time was still living like a student after college—including sleeping on the floor and driving a $200 broken car 

By
September 29, 2025
President Donald Trump smirks just off the camera in a black suit with a red tie.
Economy

All bark, no bite: Trump’s latest trade war turns into another TACO salad for Wall Street

By
September 26, 2025
Photo: WASHINGTON, DC - SEPTEMBER 25: U.S. President Donald Trump speaks in the Oval Office of the White House on September 25, 2025 in Washington, DC. Trump signed several executive orders, including approving a partial sale of TikTok's U.S. operations, following a 2024 law requiring parent company ByteDance to divest or face a ban. (Photo by Andrew Harnik/Getty Images)
Investing

Trump’s overnight demand for 100% tariffs on pharmaceuticals will be ‘a meaningful commercial hit for U.S. consumers,’ top analyst says

By
September 26, 2025
Donald Trump
Health

Scientists rebuke Trump’s Tylenol-autism claim, stress fever is bigger danger in pregnancy

By Jason Gale and Bloomberg
September 23, 2025
Swiss drug giant looks for ways to lower U.S. prices amid tariff threat and admits Americans ‘pay for a large part of the innovations’
North America

Swiss drug giant looks for ways to lower U.S. prices amid tariff threat and admits Americans ‘pay for a large part of the innovations’

By
September 20, 2025
Ben Mabey stands on a stage with an opal-colored background.
Innovation

The AI drug breakthrough is taking a long time to arrive for reasons that may have little to do with the technology’s limits

By
September 12, 2025
A new era of access demands smarter design for direct-to-consumer drug pricing
Commentary

A new era of access demands smarter design for direct-to-consumer drug pricing

By
September 5, 2025
Paul Hudson
Commentary

AI might beat IQ, not EQ — but never say never

By
September 2, 2025
Trump’s plan for hefty tax on imported drugs risks higher prices and shortages
Politics

Trump’s plan for hefty tax on imported drugs risks higher prices and shortages

By Paul Wiseman, Tom Murphy and The Associated Press
September 1, 2025
Ozempic
Health

Novo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients

By
August 18, 2025
AstraZeneca begins European exit—will invest $50 billion in the U.S. amid tariff threats
Politics

AstraZeneca begins European exit—will invest $50 billion in the U.S. amid tariff threats

By
July 22, 2025
Ireland sees thousands of jobs at risk from U.S. pharma tariffs
Workplace Culture

Ireland sees thousands of jobs at risk from U.S. pharma tariffs

By Olivia Fletcher, Stephen Carroll and Bloomberg
June 23, 2025
Bayer’s stock is charting a 40% rebound after years of losses
Finance

Bayer’s stock is charting a 40% rebound after years of losses

By Isolde MacDonogh, Tim Loh and Bloomberg
June 18, 2025
Novo Nordisk is losing Canadian patent protection on a blockbuster drug after not paying a small fee
Finance

Novo Nordisk is losing Canadian patent protection on a blockbuster drug after not paying a small fee

By
June 17, 2025

Most Popular